The influenza pandemic of 2009: Lessons and implications

Molecular Diagnosis and Therapy

Volumn 15, Issue 2, 2011, Pages 63-81

  Shapshak, Paul ^a,b   Chiappelli, Francesco ^c   Somboonwit, Charurut ^a,d   Sinnott, John ^a,d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UCLA SCHOOL OF DENTISTRY   (United States)

^d Clinical Research Unit   (United States)

Author keywords

Antivirals; Influenza A vaccines; Influenza virus infections; Viral vaccines

Indexed keywords

AMANTADINE; DNA VACCINE; FLUBLOK; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; OSELTAMIVIR; PERAMIVIR; RIMANTADINE; RNA POLYMERASE; SIALIDASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE; ZANAMIVIR;

2009 H1N1 INFLUENZA; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; DRUG EFFICACY; HUMAN; IMMUNOGENICITY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H3N8; INFLUENZA VIRUS A H5N1; MORBIDITY; MORTALITY; NONHUMAN; NOTE; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; RIBOZYME THERAPY; RNA SEQUENCE; SWINE INFLUENZA VIRUS; TREATMENT RESPONSE; UNINDEXED SEQUENCE; VIRUS GENOME; VIRUS STRAIN; VIRUS VIRULENCE;

AVES; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 79957814447     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.1007/BF03256397     Document Type: Note

References (187)

1. Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis 2006; 12 (1): 6-14
2. Bao Y, Bolotov P, Dernovoy D, et al. The Influenza Virus Resource at the National Center for Biotechnology Information. J Virol 2008; 82 (2): 596-601
3. Salomon R, Webster RG. The influenza virus enigma. Cell 2009; 136: 402-10
4. Dawood FS, Jain S, Finelli L, et al.; Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360 (25): 2605-15
5. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al.; INER Working Group on Influenza. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361: 680-9
6. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada; Canadian Critical Care Trials Group H1N1 Collaborative. JAMA 2009 Nov 4; 302 (17): 1872-9
7. Lipsitch M, Lajous M, O'Hagan JJ, et al. Use of cumulative incidence of novel influenza A/H1N1 in foreign travelers to estimate lower bounds on cumulative incidence in Mexico. PLoS One 2009 Sep 9; 4 (9): e6895
8. Centers for Disease Control and Prevention. Updated CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009-April 10, 2010 [online]. Available from URL: http://www.cdc.gov/h1n1flu/ estimates-2009-h1n1.htm [Accessed 2011 Apr 1]
9. flucount.org. End of day summary [online]. Available from URL: http://www.flucount.org [Accessed 2011 Apr 1]
10. Morens DM, Taubenberger JK, Fauci AS. The 2009 H1N1 pandemic influenza virus: what next? M Bio 2010; 1 (4): e00211-10
11. WHO. Global alert and response (GAR): influenza A(H1N1) - update 48 [online]. Available from URL: http://www.who.int/csr/don/2009-06-12/en/index. html [Accessed 2011 Apr 1]
12. Harris KM, Maurer J, Kellermann AL. Influenza vaccine: safe, effective, and mistrusted. N Engl J Med 2010; 363: 2183-5
13. Hampson AW, Mackenzie JS. Preparing for an influenza epidemic: the influenza viruses. Med J Aust 2006; 185: S39-43
14. Beran GW. Disease and destiny: mystery and mastery. Prev Vet Med 2008 Sep 15; 86 (3-4): 198-207
15. Chow A, Ma S, Ling AE, et al. Influenza-associated deaths in tropical Singapore. Emerg Infect Dis 2006; 12: 114-21 (Pubitemid 43143546)
16. Cruveilhier L. Action du sérum antipneumococcique au cours de la pneumonie et dans les complications de la grippe. Ann Inst Pasteur (Paris) 1919; 33: 448-61
17. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198: 962-70
18. Bishop JF, Murnane MP, Owen R. Australia's winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med 2009; 361: 2591-4
19. Lessler J, Reich NG, Cummings DAT, and the New York City Department of Health and Mental Hygiene Swine Influenza Investigation Team. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. N Engl J Med 2009; 361: 2628-36
20. Cauchemez S, Donnelly CA, Reed C, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009; 361: 2619-27
21. Ito T, Nelson J, Couceiro SS, et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 1998; 72: 7367-73 (Pubitemid 28377868)
22. Easterday BC, Van Reeth K. Swine influenza. In: Straw BE, D'Allaire SD, Mengeling WL, editors. Diseases of swine. 8th ed. Ames (IA): Iowa State University Press, 1999: 277-90
23. Thacker E, Janke B. Swine influenza virus: zoonotic potential and vaccination strategies for the control of avian and swine influenzas. J Infect Dis 2008; 197: S19-24
24. Kothalawala H, Toussaint MJ, Gruys E. An overview of swine influenza. Vet Q 2006; 28: 46-53
25. Shinde V, Bridges CB, Uyeki TM, et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 2009; 360: 1-10
26. Olsen CW. The emergence of novel swine influenza viruses in North America. Virus Res 2002; 85: 199-210 (Pubitemid 34606914)
27. Lekcharoensuk P, Lager KM, Vemulapalli R, et al. Novel swine influenza virus subtype H3N1, United States. Emerg Infect Dis 2006; 12: 787-92
28. Shin JY, Song MS, Lee EH, et al. Isolation and characterization of novel H3N1 swine influenza viruses from pigs with respiratory diseases in Korea. J Clin Microbiol 2006; 44: 3923-7 (Pubitemid 44737230)
29. Karasin AI, Schutten MM, Cooper LA, et al. Genetic characterization of H3N2 influenza viruses isolated from pigs in North America, 1977-1999: evidence for wholly human and reassortant virus genotypes. Virus Res 2000; 68: 71-85
30. Webby RJ, Swenson SL, Krauss SL, et al. Evolution of swine H3N2 influenza viruses in the United States. J Virol 2000; 74: 8243-51 (Pubitemid 30666672)
31. Karasin AI, West K, Carman S, et al. Characterization of avian H3N3 and H1N1 influenza A viruses isolated from pigs in Canada. J Clin Microbiol 2004; 42: 4349-54 (Pubitemid 39296175)
32. Campitelli L, Donatelli I, Foni E, et al. Continued evolution of H1N1 and H3N2 influenza viruses in pigs in Italy. Virology 1997; 232: 310-8 (Pubitemid 27293574)
33. Kamps BS, Reyes-Terá n G. Chapter 1: influenza 2006. In: Kamps BS, C Hoffmann C, W Preiser W, editors. Influenza report 2006 [online]. Available from URL: www.influenzareport.com [Accessed 2011 Apr 1]
34. Dias A, Bouvier D, Cré pin T, et al. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 2009; 458: 914-8
35. Li OT, Chan MC, Leung CS, et al. Full factorial analysis of mammalian and avian influenza polymerase subunits suggests a role of an efficient polymerase for virus adaptation. PLoS One 2009 May 21; 4 (5): e5658
36. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009; 459: 931-40
37. Guilligay D, Tarendeau F, Resa-Infante P, et al. The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat Struct Mol Biol 2008; 15 (5): 500-6 (Pubitemid 351653591)
38. Burgui I, Angüez E, Sonenberg N, et al. Influenza virus mRNA translation revisited: is the eIF4E cap-binding factor required for viral mRNA translation? J Virol 2007; 81: 12427-38
39. Conenello GM, Palese P. Influenza A virus PB1-F2: a small protein with a big punch. Cell Host Microbe 2007; 2: 207-9 (Pubitemid 47500827)
40. Conenello G, Zamarin D, Perrone LA, et al. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 2007; 3: 1414-21
41. Khanna M, Gupta N. Influenza A (H1N1) pandemic: preparedness and clinical management. Ind J Exp Biol 2009; 47: 929-32
42. McAuley JL, Hornung F, Boyd KL, et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2007; 2: 2240-9
43. Trifonov V, Racaniello V, Rabadan R. The contribution of the PB1-F2 protein to the fitness of influenza A viruses and its recent evolution in the 2009 influenza A (H1N1) pandemic virus. PLoS Curr 2009 Aug 21; 1: RRN1006
44. Schnitzler SU, Schnitzler P. An update on swine-origin influenza virus A/H1N1: a review. Virus Genes 2009; 39: 279-92
45. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325: 197-201
46. Niman HL. Swine influenza A evolution via recombination - genetic drift reservoir. Nature Precedings 2007 Jul 7 [online]. Available from URL: http://precedings.nature.com/documents/385/version/1/files/npre2007385-1.pdf [Accessed 2011 Apr 1]
47. Shen J, Ma J, Wang Q. Evolutionary trends of A (H1N1) influenza virus hemagglutinin since 1918. PLoS One 2009 Nov 17; 4 (11): e7789
48. Suarez DL, Senne DA, Banks J, et al. Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerg Infect Dis 2004; 10: 693-9 (Pubitemid 38420303)
49. Santibañez S, Fiore AE, Merlin TL, et al. A primer on strategies for prevention and control of seasonal and pandemic influenza. Am J Public Health 2009 Oct; 99 Suppl. 2: S216-24
50. Neumann G, Kawaoka Y. Reverse genetics of influenza virus. Virol 2001 Sep 1; 287 (2): 243-50 (Pubitemid 32804010)
51. McAuley JL, Zhang K, McCullers JA. The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol 2010 Jan; 84 (1): 558-64
52. Khanna M, Kumar P, Prasad AK. Influenza and its role in apoptosis. Indian Journal of Allergy Asthma and Immunology 2001 Jan-Jun; 15 (1): 7-12
53. Uiprasertkul M, Kitphati R, Puthavathana P, et al. Apoptosis and pathogenesis of avian influenza A(H5N1) virus in humans. Emerg Infect Dis 2007; 13: 708-12 (Pubitemid 46698732)
54. Herold S, Steinmueller M, von Wulffen W, et al. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med 2008; 205: 3065-77
55. Allen JE, Gardner SN, Vitalis EA, et al. Conserved amino acid markers from past influenza pandemic strains. BMC Microbiology 2009; 9: 77-100
56. Belshe RB, Morens DM. The origins of pandemic influenza: lessons from the 1918 virus. N Engl J Med 2005; 353: 2209-11
57. Finkelstein DB, Mukatira S, Mehta PK, et al. Persistent host markers in pandemic and H5N1 influenza viruses. J Virol 2007; 81: 10292-9 (Pubitemid 47463304)
58. Chen GW, Chang SC, Mok CK, et al. Genomic signatures of human versus avian influenza A viruses. Emerg Infect Dis 2006; 12: 1353-60
59. Chaipan C, Kobasa D, Bertram S, et al. Proteolytic activation of the 1918 influenza virus hemagglutinin. J Virol 2009; 83 (7): 3200-11
60. Stieneke-Gröber A, Vey M, Angliker H, et al. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J 1992 Jul; 11 (7): 2407-14
61. Reid AH, Fanning TG, Hultin JV, et al. Origin and evolution of the 1918 Spanish influenza virus hemagglutinin gene. Proc Natl Acad Sci U S A 1999; 96: 1651-6
62. Cohen J. Pandemic influenza: straight from the pig's mouth. Swine research with swine influenzas. Science 2009 Jul 10; 325 (5937): 140-1
63. Khiabanian H, Trifonov V, Rabadan R. Reassortment patterns in swine influenza viruses. PLoS One 2009; 4 (10): 1-7
64. Qi X, Lu C. Swine influenza virus: evolution mechanism and epidemic characterization. A review [article in Chinese; abstract in English]. Wei Sheng Wu Xue Bao 2009 Sep 4; 49 (9): 1138-45
65. Hilleman MR. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 2002; 20 (25-26): 3068-87
66. De Jong JC, Rimmelzwaan GF, Fouchier RA, et al. Influenza virus: a master of metamorphosis. J Infect 2000; 40 (3): 218-28 (Pubitemid 30447176)
67. Ferguson NM, Galvani AP, Bush RM. Ecological and immunological determinants of influenza evolution. Nature 2003; 422 (6930): 428-33 (Pubitemid 36411395)
68. Varich NL, Gitel'man AK, Shilov AA, et al. Differential incorporation of genomic segments into the influenza A virus reassortants in mixed infection. Vopr Virusol 2009 Jan-Feb; 54 (1): 7-11
69. Nayak DP, Baloguna RA, Yamada H, et al. Influenza virus morphogenesis and budding. Virus Res 2009 Aug; 143 (2): 147-61
70. Fitch WM, Leiter JM, Li XQ, et al. Positive Darwinian evolution in human influenza A viruses. Proc Natl Acad Sci U S A 1991 May 15; 88 (10): 4270-4 (Pubitemid 21914521)
71. Morens DM, Taubenberger JK, Harvey HA, et al. The 1918 influenza pandemic: lessons for 2009 and the future. Crit Care Med 2010 Apr; 38 (4 Suppl.): e10-20
72. Suzuki Y, Nei M. Origin and evolution of influenza virus hemagglutinin genes. Mol Biol Evol 2002; 19: 501-9 (Pubitemid 34289425)
73. Clemow FG. Epidemic influenza. Public Health 1889-90; 2: 358-67
74. Clemow FG. The geography of disease. Cambridge: Cambridge University Press, 1903: 187-203
75. Morens DM, Fauci AS. The 1918 influenza pandemic: insights for the 21st century. J Infect Dis 2007; 195: 1018-28
76. Potter CW. A history of influenza. J Appl Microbiol 2001; 91 (4): 572-9 (Pubitemid 32948377)
77. Hilleman M. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 2002; 20: 3068-87
78. Taubenberger JK, Morens DM. 1918 influenza: the mother of all pandemics. Emerg Infect Dis 2006; 12 (1): 15-22
79. Cadham FT. The use of a vaccine in the recent epidemic of influenza. Can Med Assoc J 1919; 9: 519-27
80. Beveridge WI. The chronicle of influenza epidemics. Hist Philos Life Sci 1991; 13 (2): 223-34
81. Center for Infectious Disease Research & Policy [CIDRAP], University of Minnesota. Pandemic influenza: pandemics of the 20th century [online]. Available from URL: http://www.cidrap.umn.edu/cidrap/content/influenza/panflu/ biofacts/panflu.html#-Pandemics-of-the-20th-Century [Accessed 2011 Apr 1]
82. Kilbourne ED, Smith C, Brett I, et al. The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic [published erratum appears in Proc Natl Acad Sci U S A 2003 Jan 21; 100 (2): 764]. Proc Natl Acad Sci U S A 2002 Aug 6; 99 (16): 10748-52
83. Nobel Media AB. Sir Frank Macfarlane Burnet - biography [online]. Available from URL: http://nobelprize.org/nobel-prizes/medicine/laureates/1960/ burnet.html [Accessed 2011 Apr 1]
84. Kendall H. Vaccine innovation: lessons from World War II. J Public Health Policy 2006; 27 (1): 38-57
85. UniProt Consortium. Influenza A virus (strain A/USA:Huston/AA/1945 H1N1) [online]. Available from URL: http://www.uniprot.org/taxonomy/425551 [Accessed 2011 Apr 1]
86. Influenza prophylaxis: prophylactic vaccinations [online]. Available from URL: http://www.en.influenza.pl/ida/prophylactic-vaccinations.html [Accessed 2011 Apr 1]
87. Francis Jr T, Salk JE, Quilligan Jr JJ. Experience with vaccination against influenza in the spring of 1947. Am J Public Health 1947; 37: 1013-6
88. UniProt Consortium. Influenza A virus strains of 1946 [online]. Available from URL: http://www.uniprot.org/taxonomy/?query=influenza+1946++&sort= score [Accessed 2011 Apr 1]
89. Viboud C, Tam T, Fleming D, et al. 1951 influenza epidemic, England and Wales, Canada, and the United States. Emerg Infect Dis 2006 Apr; 12 (4): 661-8
90. Dauer CC, Serfling RE. Mortality from influenza 1957-1958 and 1959-1960. Am Rev Respir Dis 1961; 83 (Suppl.): 15-28
91. Henderson DA, Courtney B, Inglesby TV, et al. Public health and medical responses to the 1957-58 influenza pandemic. Biosecur Bioterror 2009; 7 (3): 265-73
92. Williams MC, Davignon L, McDonald JC, et al. Trials of aqueous killed influenza vaccine in Canada, 1968-1969. Bull World Health Org 1973; 49: 333-40
93. Alling DW, Blackwelder WC, Stuart-Harris CH. A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol 1981; 113: 30-43
94. Knight V, Couch RB, Douglas RIG, et al. Serological responses and results of natural infectious challenge of recipients of zonal ultracentrifuged influenza A2/Aichi/2/68 vaccine. Bull World Health Org 1971; 45: 767-71
95. Gaydos JC, Top FH, Hodder RA, et al. Swine influenza A outbreak, Fort Dix, New Jersey, 1976. Emerg Infect Disease 2006 Jan; 12 (1): 23-8
96. Beveridge WIB. Where did red flu come from? New Scientist 1978; 23: 790-1
97. Halperin W, Weiss WI, Altman R, et al. A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: report of a study and review of the literature. Am J Public Health 1979; 69: 1247-50
98. Pons VG, Canter J, Dolin R. Influenza A/USSR/77 (H1N1) on a university campus. Am J Epidemiol 2006; 111 (1): 23-30
99. Centers for Disease Control and Prevention. Influenza: People's Republic of China. MMWR Morb Mortal Wkly Rep 1978; 27: 24
100. Centers for Disease Control and Prevention. Influenza: United States, USSR, Hong Kong. MMWR Morb Mortal Wkly Rep 1978; 27: 16
101. Zhdanov VM, Zakstelskaya LY, Isachenko VI, et al. Return of epidemic Al influenza virus. Lancet 1978; 1: 294-5
102. Kendal AP, Joseph JM, Kobayashi G, et al. Laboratory-based surveillance of influenza virus in the United States during the winter of 1977-1978: I. Periods of prevalence of H1N1 and H3N2 influenza A strains, their relative rates of isolation in different age groups, and detection of antigenic variants. Am J Epidemiol 1979; 110: 449-61
103. Glezen WP, Keitel WA, Taber LH, et al. Age distribution of patients with medically attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989. Am J Epidemiol 1991; 133: 296-304
104. Mast EE, Harmon MW, Gravenstein S, et al. Emergence and possible transmission of amantadine resistant viruses during nursing home outbreaks of influenza A (H3N2). Am J Epidemiol 1991; 134 (9): 988-77
105. Centers for Disease Control and Prevention. Update on influenza activity - United States and worldwide, with recommendations for influenza vaccine composition for the 1988-89 season. MMWR Morb Mortal Wkly Rep 1988; 37: 241-4
106. Webster RG, Peiris M, Chen H, et al. H5N1 outbreaks and enzootic influenza. Emerg Infect Dis 2006; 12: 3-8 (Pubitemid 43143527)
107. Morens DM, Taubenberger JK, Folkers GK, et al. An historical antecedent of modern guidelines for community pandemic influenza mitigation. Public Health Rep 2009; 124: 22-5
108. WHO. Global alert and response (GAR): cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO, 10 September 2008 [online]. Available from URL: http://www.who.int/csr/disease/avian-influenza/ country/cases-table-2008-09-10/en/index.html [Accessed 2011 Apr 1]
109. US FDA. Influenza virus vaccine composition and lot release [online]. Available from URL: http://www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ UCM062928 [Accessed 2011 Apr 1]
110. Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353: 1374-85
111. Kaverin NV, Rudneva IA, Govorkova EA, et al. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol 2007; 81: 12911-7 (Pubitemid 350156928)
112. Peiris JS, de Jong MD, Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 2007; 20: 243-67 (Pubitemid 46709304)
113. UniProt Consortium. Influenza A virus strains of 2003 [online]. Available from URL: http://www.uniprot.org/taxonomy/?query=influenza+2003&sort=score [Accessed 2011 Apr 1]
114. Greenberg ME, Lai MH, Hartel GF, et al. Response to a monovalent influenza A (H1N1) vaccine. N Engl J Med 2009: 361; 2405-13
115. CSL Limited. A clinical trial of CSL's 2009 H1N1 influenza vaccine (CSL425) in healthy adults [ClinicalTrials.gov identifier NCT00938639]. US National Institutes of Health, ClinicalTrials.gov [online]. Available fromURL: http://www.clinicaltrials.gov/ct2/show/NCT00938639?id=NCT00938639&rank=1 [Accessed 2011 Apr 1]
116. Clark TW, Pareek M, Hoschler K, et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009; 361 (25): 2424-35
117. Braithwaite S, Handrigan MT. Novel H1N1 influenza. Emerg Med Rep 2010; 31: 1-11
118. Centers for Disease Control and Prevention. Laboratory confirmed influenza-associated hospitalizations and deaths from August 30 2009 to April 3, 2010 [online]. Available from URL: http://www.cdc.gov/h1n1flu/updates/us/ #totalcases [Accessed 2011 Apr 1]
119. WHO. Global alert and response (GAR): pandemic (H1N1) 2009 [online]. Available from URL: http://www.who.int/csr/disease/swineflu/en/index.html [Accessed 2011 Apr 1]
120. Chien YW, Klugman KP, Morens DM. Efficacy of whole-cell killed bacterial vaccines in preventing pneumonia and death during the 1918 influenza pandemic. J Infect Dis 2010; 202 (11): 1639-48
121. Rogers DE, Louria DB, Kilbourne ED. The syndrome of fatal influenza virus pneumonia. Trans Assoc Am Physicians 1958; 71: 260-73
122. Choppin PW, Tamm I. Studies of two kinds of virus particles, which comprise influenza A2 virus strains: II. Reactivity with virus inhibitors in normal sera. J Exp Med 1960; 112: 921-44
123. Schulman JL, Kilbourne ED. Independent variation in nature of the hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of the hemagglutinin antigen of Hong Kong-68 virus. Proc Natl Acad Sci U S A 1969; 63: 326-33
124. Stuart-Harris C. Epidemiology of influenza in man. Br Med Bull 1979; 35: 3-8 (Pubitemid 9096964)
125. Monto AS, Kendal AP. Effect of neuraminidase antibody on Hong Kong influenza. Lancet 1973; 1: 623-5
126. Viboud C, Grais RF, Lafont BA, et al.; Multinational Influenza Seasonal Morbidity Study Group. Multinational impact of the 1968 Hong Kong pandemic: evidence for a smoldering pandemic. J Infect Dis 2005; 192: 223-48
127. Mermel LA. Swine-origin influenza virus in young age groups. Lancet 2009; 373: 2108-9
128. Igarashi M, Ito K, Yoshida R, et al. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS One 2010 Jan 1; 5 (1): e8553
129. Krause JC, Tumpey TM, Huffman CJ, et al. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. J Virol 2010 Mar; 84 (6): 3127-30
130. Alexander DJ. An overview of the epidemiology of avian influenza. Vaccine 2007; 25: 5637-44 (Pubitemid 47031360)
131. Center for Infectious Disease Research & Policy [CIDRAP], University of Minnesota. Launch of WHO H5N1 vaccine stockpile still awaited [online]. Available from URL: http://www.cidrap.umn.edu/cidrap/content/influenza/panflu/ news/may1608vaccine.html [Accessed 2011 Apr 1]
132. Sambhara S, Poland GA. H5N1 avian influenza: preventive and therapeutic strategies against a pandemic. Ann Rev Med 2010; 61: 187-98
133. McCullers JA. Preparing for the next influenza pandemic. Pediatr Infect Dis J 2008 Oct; 27 (10 Suppl.): S57-9
134. Shope RE. Swine influenza: I. Experimental transmission and pathology. J Exp Med 1931; 54: 349-59
135. Shope RE. Swine influenza: III. Filtration experiments and etiology. J Exp Med 1931; 54: 373-85
136. Lewis PA, Shope RE. Swine influenza: II. A hemophilic bacillus from the respiratory tract of infected swine. J Exp Med 1931; 54: 361-71
137. Horsfall FL, Lennette EH, Rickard RE. A complex vaccine against influenza A virus. J Exp Med 1941; 73: 335-55
138. Horsfall Jr FL, Lennette EH. A complex vaccine effective against different strains of influenza virus. Science 1940; 91: 492-5
139. Horsfall FL, Lennette EH. The synergism of human influenza and canine distemper viruses in ferrets. J Exp Med 1941; 72: 247-59
140. Ginsberg HS, Horsfall FL. Concurrent infection with influenza virus and mumps virus or pneumonia virus of mice as bearing on the inhibition of virus multiplication by bacterial polysaccharides. J Exp Med 1949 Jan; 89 (1): 37-52
141. Couch RB. Seasonal inactivated influenza virus vaccines. Vaccine 2008; 26 (Suppl. 4): D5-9
142. Legastelois I, Garcia-Sastre A, Palese P, et al. Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells. Influenza Other Respir Viruses 2007 May; 1 (3): 95-104
143. Biere B, Schweiger B. Molecular analyses of human influenza viruses: circulation of new variants since 1995/96. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2008 Sep; 51 (9): 1050-60
144. Iwami S, Suzuki T, Takeuchi Y. Paradox of vaccination: is vaccination really effective against avian flu epidemics? PLoS One 2009; 4 (3): e4915
145. Schweiger B, Bruns L, Meixenberger K. Reassortment between human A(H3N2) viruses is an important evolutionary mechanism. Vaccine 2006 Nov 10; 24 (44-46): 6683-90 (Pubitemid 46107168)
146. He CQ, Han GZ, Wang D, et al. Homologous recombination evidence in human and swine influenza A viruses. Virology 2008 Oct 10; 380 (1): 12-20
147. WHO. Global alert and response (GAR): recommendations for influenza vaccines [online]. Available from URL: http://www.who.int/csr/disease/influenza/ vaccinerecommendations/en/index.html [Accessed 2011 Apr 1]
148. Centers for Disease Control and Prevention. 2009 H1N1 vaccination recommendations [online]. http://www.cdc.gov/h1n1flu/vaccination/acip.htm [Accessed 2011 Apr 1]
149. Fiore AE, Shay DK, Broder K, et al.; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008; 57 (RR-7): 1-60
150. American Academy of Pediatrics. Implementation guidance - seasonal influenza [online]. Available from URL: http://www.aap.org/immunization/ illnesses/flu/ImplementationGuidance-Flu.pdf [Accessed 2011 Apr 1]
151. Lo AS, Zhu Q, Marasco WA. Intracellular antibodies (intrabodies) and their therapeutic potential. Handb Exp Pharmacol 2008; 181: 343-73
152. Mann A, Marriott AC, Balasingam S, et al. Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection. Vaccine 2006 May 15; 24 (20): 4290-6
153. DeVincenzo JP. RNA interference strategies as therapy for respiratory viral infections. Pediatr Infect Dis J 2008 Oct; 27 (10 Suppl.): S118-22
154. Saravolac EG, Wong JP. Recent patents on development of nucleic acid-based antiviral drugs against seasonal and pandemic influenza virus infections. Recent Pat Antiinfect Drug Discov 2007 Jun; 2 (2): 140-7 (Pubitemid 46952437)
155. King Jr JC, Cox MM, Reisinger K, et al. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months. Vaccine 2009; 27 (47): 6589-94
156. Mahmood K, Bright RA, Mytle N, et al. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. Vaccine 2008; 26 (42): 5393-9
157. Drape RJ, Macklin MD, Barr LJ, et al. Epidermal DNA vaccine for influenza is immunogenic in humans. Vaccine 2006 May 22; 24 (21): 4475-81 (Pubitemid 43776768)
158. Schotsaert M, De FM, Fiers W, et al. Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Rev Vaccines 2009; 8: 499-508
159. McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007; 45: 1568-75 (Pubitemid 351411840)
160. Furuse Y, Suzuki A, Shimizu M, et al. Reassortment between amantadine-resistant and -sensitive H1N1 influenza A viruses generated an amantadine-sensitive virus during the 2007-2008 season. J Infect Disease 2009 Dec 1; 200 (11): 1766-73
161. WHO. Global alert and response (GAR): Antiviral drugs for pandemic (H1N1) 2009: definitions and use [online]. Available from URL: http://www.who.int/csr/ disease/swineflu/frequently-asked-questions/antivirals/definitions-use/en/index. html [Accessed 2011 Apr 1]
162. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005; 353: 1363-73 (Pubitemid 41362704)
163. Gerloff NA, Kremer JR, Mossong J, et al. Genomic diversity of oseltamivir-resistant influenza virus A (H1N1), Luxembourg, 2007-08. Emerg Infect Dis 2009 Sep; 15 (9): 1523-4
164. Smee DF, Sidwell RW. Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza. Exp Opin Investig Drugs 2002; 11 (6): 859-69 (Pubitemid 34618818)
165. BioCryst Pharmaceuticals. Safety study of IV peramivir in hospitalized subjects with confirmed or suspected influenza [ClinicalTrials.gov identifier NCT00957996]. US National Institutes of Health, ClinicalTrials.gov [online]. Available from URL: http://www.clinicaltrials.gov/ct2/show/NCT00957996?id= NCT00957996&rank=1 [Accessed 2011 Apr 1]
166. Webster RG, Kawaoka Y, Bean WJ, et al. Chemotherapy and vaccination: a possible strategy for the control of highly virulent influenza virus. J Virol 1985 July; 55 (1): 173-6 (Pubitemid 15048704)
167. Longini Jr IM, Halloran ME, Nizam A, et al. Containing pandemic influenza with antiviral agents. Am J Epidemiol 2004; 159 (7): 623-33 (Pubitemid 38405377)
168. Dharan NJ, Patton M, Siston AM, et al. Outbreak of antiviral drug-resistant influenza A in long-term care facility, Illinois, USA, 2008. Emerg Infect Dis 2009 Dec; 15 (12): 1973-6
169. Lazarev VN, Shmarov MM, Zakhartchouk AN, et al. Inhibition of influenza A virus reproduction by a ribozyme targeted against PB1 mRNA. Antiviral Res 1999 May; 42 (1): 47-57 (Pubitemid 29234148)
170. Sui HY, Zhao GY, Huang JD, et al. Small interfering RNA targeting m2 gene induces effective and long term inhibition of influenza A virus replication. PLoS One 2009 May 22; 4 (5): e5671
171. Bitko V, Barik S. Nasal delivery of siRNA. Methods Mol Biol 2008; 442: 75-82
172. Wong JP, Christopher ME, Salazar AM, et al. Broad-spectrum and virus-specific nucleic acid-based antivirals against influenza. Front Biosci (Schol Ed) 2010 Jan 1; 2: 791-800
173. Zhang S, Yan P, Winchester B, et al. Transmissibility of the 1918 pandemic influenza in Montreal and Winnipeg of Canada. Influenza Other Respi Viruses 2010 Jan; 4 (1): 27-31
174. HHS.gov. HHS pandemic influenza plan [online]. Available from URL: http://www.hhs.gov/pandemicflu/plan/ [Accessed 2011 Apr 1]
175. Stohr K. Overview of the WHO Global Influenza Programme. Dev Biol (Basel) 2003; 115: 3-8
176. WHO. Global alert and response (GAR): WHO collaborating centres for influenza and essential regulatory laboratories [online]. Available from URL: http://www.who.int/csr/disease/influenza/collabcentres/en/index.html [Accessed 2011 Apr 1]
177. Butler D. Flu database rocked by legal row. Nature 2009 Aug; 460: 786-7 [online]. Available from URL: http://www.nature.com/news/2009/090812/pdf/ 460786b.pdf [Accessed 2011 Apr 1]
178. Center for Infectious Disease Research & Policy [CIDRAP], University of Minnesota. German Government to host flu database [media release]. 2009 Oct 20 [online]. Available from URL: http://www.cidrap.umn.edu/cidrap/content/ influenza/general/news/oct2009gisaid.html [Accessed 2011 Apr 1]
179. American Public Health Association. Influenza: report of a special committee of the American Public Health Association. J Am Med Assoc 1918; 71: 2068-73
180. Pottevin H. Rapport sur la pandémie grippale de 1918-1919 présenté au Comité Permanent de l'Office Internationale d'Hygiène Publique. Bulletin de l'Office Internationale d'Hygiène Publique 1921; 13: 125-81
181. Flu.gov. Community strategy for pandemic influenza mitigation [online]. Available from URL: http://pandemicflu.gov/professional/community/commitigation. html [Accessed 2011 Apr 1]
182. Baral S, Sherman SG, Millson P, et al. Vaccine immunogenicity in injecting drug users: a systematic review. Lancet Infect Dis 2007; 7: 667-74 (Pubitemid 47444565)
183. Boschini A, Longo B, Caselli F, et al. An outbreak of influenza in a residential drug-rehabilitation community. J Med Virol 2006; 78: 1218-22 (Pubitemid 44182239)
184. Baral S, Sherman SG, Millson P, et al. Vaccine immunogenicity in injecting drug users: a systematic review. Lancet Infect Dis 2007 Oct; 7 (10): 667-74 (Pubitemid 47444565)
185. Stancliff S, Salomon N, Perlman DC, et al. Provision of influenza and pneumococcal vaccines to injection drug users at a syringe exchange. J Subst Abuse Treat 2000 Apr; 18 (3): 263-5 (Pubitemid 30163031)
186. Bragstad K, Nielsen LP, Fomsgaard A. The evolution of human influenza A viruses from 1999 to 2006: a complete genome study. Virol J 2008 Mar 7; 5: 40-53
187. Zarocostas J. External committee is to look at criticisms of WHO's management of H1N1 pandemic. BMJ 2010; 340: 2342-3